Matt Madeksza
Known title: President - Transit PackagingCIK: 0001941490
Associated companies
Transaction History
| CCK | ▼ Sell | Tax Withholding | 984 | $95K | 5/15/2026 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 1,756 | $203K | 2/26/2026 | View on chart |
| CCK | ▲ Buy | Grant | 744 | $0 | 2/26/2026 | View on chart |
| CCK | ▲ Buy | Grant | 3,168 | $0 | 1/5/2026 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 2,737 | $289K | 1/5/2026 | View on chart |
| CCK | ▲ Buy | Grant | 11,069 | $0 | 1/5/2026 | View on chart |
| CCK | ▼ Sell | Open Market | 1,500 | $149K | 6/6/2025 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 609 | $61K | 5/15/2025 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 698 | $56K | 1/6/2025 | View on chart |
| CCK | ▲ Buy | Grant | 13,642 | $0 | 1/3/2025 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 984 | $83K | 5/15/2024 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 549 | $50K | 1/4/2024 | View on chart |
| CCK | ▲ Buy | Grant | 10,115 | $0 | 1/3/2024 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 609 | $50K | 5/15/2023 | View on chart |
| CCK | ▲ Buy | Grant | 10,603 | $0 | 1/4/2023 | View on chart |
| CCK | ▼ Sell | Tax Withholding | 609 | $48K | 11/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Cuts Crown Holdings Price Target to $116
UBS has lowered its price target for Crown Holdings to $116 while maintaining a Neutral rating. This new target is below the current support level of $118.66, suggesting potential downside pressure. The move stands out as the new target is significantly lower than the average analyst estimate of $136.57.
UBS Cuts Crown Holdings Price Target to $116. UBS has lowered its price target for Crown Holdings to $116 while maintaining a Neutral rating. This new target is below the current support level of $118.66, suggesting potential downside pressure. The move stands out as the new target is significantly lower than the average analyst estimate of $136.57.